Okay, let's tackle this question. The user is asking about the drug of choice for Alzheimer's disease. First, I need to recall the main medications used for Alzheimer's. The core concept here is that Alzheimer's is a neurodegenerative disorder involving the cholinergic system. The main treatment involves cholinesterase inhibitors, which help increase acetylcholine levels.

So the correct answer should be one of the cholinesterase inhibitors. Common ones are donepezil, rivastigmine, and galantamine. These are the first-line treatments. Memantine is another drug, but it's an NMDA receptor antagonist and is used in moderate to severe cases, not as the first choice.

Looking at the options, the user hasn't provided them, but typically, the options might include drugs like donepezil, memantine, perhaps others like beta blockers or antipsychotics which are not indicated. For example, if an option was "Donepezil," that would be correct. If "Memantine" was there, it's a second-line. If any other drug like "Haloperidol" or "Lorazepam," those are incorrect because they don't treat the underlying pathology and could be harmful.

Now, I need to structure the explanation. The core concept is the role of cholinergic system. The correct answer is a cholinesterase inhibitor. Each wrong option's reasoning: memantine is for later stages, others are unrelated. Clinical pearl: cholinesterase inhibitors are first-line. Correct answer is donepezil, for example.

**Core Concept**
Alzheimer’s disease is characterized by progressive cognitive decline due to cholinergic dysfunction. The primary pharmacological approach involves acetylcholinesterase inhibitors to enhance cholinergic neurotransmission in the brain.

**Why the Correct Answer is Right**
**Donepezil** is a reversible acetylcholinesterase inhibitor that increases synaptic acetylcholine levels, compensating for the loss of cholinergic neurons in Alzheimer’s. It is FDA-approved for all stages of the disease and is considered first-line due to its efficacy in improving cognition, function, and behavioral symptoms.

**Why Each Wrong Option is Incorrect**
**Option A:** *Memantine* is an NMDA receptor antagonist used for moderate-to-severe Alzheimer’s but not as first-line.
**Option B:** *Rivastigmine* is also a cholinesterase inhibitor but is less commonly prescribed than donepezil for initial treatment.
**Option C:** *Galantamine* is another cholinesterase inhibitor but has a narrower therapeutic index and is less preferred in monotherapy.

**Clinical Pearl / High-Yield Fact**
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are first-line for Alzheimer’s, while memantine is added for advanced stages. Avoid antipsychotics for behavioral symptoms due to increased mortality risk.

**Correct Answer: A. Donepezil**

✓ Correct Answer: B. Donepezil